BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 180 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $6,425,000 | +6.1% | 82,309 | -13.7% | 3.01% | +11.0% |
Q2 2018 | $6,053,000 | -39.8% | 95,352 | -13.0% | 2.71% | -41.7% |
Q1 2018 | $10,055,000 | -1.7% | 109,652 | -19.1% | 4.66% | -0.1% |
Q4 2017 | $10,224,000 | -14.6% | 135,585 | -21.1% | 4.66% | -9.3% |
Q3 2017 | $11,971,000 | -22.2% | 171,822 | -43.4% | 5.14% | -28.4% |
Q2 2017 | $15,385,000 | -21.9% | 303,641 | -38.3% | 7.18% | -27.6% |
Q1 2017 | $19,689,000 | +0.1% | 492,341 | -29.8% | 9.92% | -6.7% |
Q4 2016 | $19,663,000 | – | 700,991 | – | 10.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |